Danaher (DHR) Higher, Sees Q4 EPS Exceeding Previous Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts DHR Hot Sheet
Price: $219.81 +1.08%
EPS Growth %: +1.6%
Financial Fact:
Earnings from continuing operations: 402.6M
Today's EPS Names:
HOVR, VFS, PGR, More
EPS Growth %: +1.6%
Financial Fact:
Earnings from continuing operations: 402.6M
Today's EPS Names:
HOVR, VFS, PGR, More
Join SI Premium – FREE
Danaher Corporation (NYSE: DHR) shares have been higher all session following a regulatory filing earlier.
The company said CEO H. Lawrence Culp, Jr., will be presenting at the J.P. Morgan Healthcare Conference today and it expects to exceed the high-end of previous fourth-quarter 2012 EPS guidance.
Shares are up 3.6 percent on the session.
The full release is below.
Danaher Corporation announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company’s performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company’s fourth quarter 2012 diluted net earnings per share is anticipated to be above the high end of the previously announced range of $0.80-0.85, with higher than expected core revenue growth in the quarter.
*** The Street consensus calls for Q412 EPS of $0.83.
Mr. Culp stated: “We are pleased by the strong finish to the year from both a revenue and earnings perspective, which was broad-based across most of our businesses.”
The company said CEO H. Lawrence Culp, Jr., will be presenting at the J.P. Morgan Healthcare Conference today and it expects to exceed the high-end of previous fourth-quarter 2012 EPS guidance.
Shares are up 3.6 percent on the session.
The full release is below.
Danaher Corporation announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company’s performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company’s fourth quarter 2012 diluted net earnings per share is anticipated to be above the high end of the previously announced range of $0.80-0.85, with higher than expected core revenue growth in the quarter.
*** The Street consensus calls for Q412 EPS of $0.83.
Mr. Culp stated: “We are pleased by the strong finish to the year from both a revenue and earnings perspective, which was broad-based across most of our businesses.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- HIMS jumps 7% on peptide tailwind but Citi sees 17% downside from here
- Mangoceuticals closes $500K offering at 74% premium to recent price
Create E-mail Alert Related Categories
Guidance, Insiders' BlogRelated Entities
JPMorgan, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
